These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15578951)
1. Progress in thioaptamer development. Yang X; Gorenstein DG Curr Drug Targets; 2004 Nov; 5(8):705-15. PubMed ID: 15578951 [TBL] [Abstract][Full Text] [Related]
2. Selection of thioaptamers for diagnostics and therapeutics. Yang X; Wang H; Beasley DW; Volk DE; Zhao X; Luxon BA; Lomas LO; Herzog NK; Aronson JF; Barrett AD; Leary JF; Gorenstein DG Ann N Y Acad Sci; 2006 Oct; 1082():116-9. PubMed ID: 17145932 [TBL] [Abstract][Full Text] [Related]
3. Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase. Somasunderam A; Ferguson MR; Rojo DR; Thiviyanathan V; Li X; O'Brien WA; Gorenstein DG Biochemistry; 2005 Aug; 44(30):10388-95. PubMed ID: 16042416 [TBL] [Abstract][Full Text] [Related]
4. Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50. King DJ; Bassett SE; Li X; Fennewald SA; Herzog NK; Luxon BA; Shope R; Gorenstein DG Biochemistry; 2002 Jul; 41(30):9696-706. PubMed ID: 12135392 [TBL] [Abstract][Full Text] [Related]
5. Development of Phosphorothioate DNA and DNA Thioaptamers. Volk DE; Lokesh GLR Biomedicines; 2017 Jul; 5(3):. PubMed ID: 28703779 [TBL] [Abstract][Full Text] [Related]
6. Thioaptamer interactions with prion proteins: sequence-specific and non-specific binding sites. King DJ; Safar JG; Legname G; Prusiner SB J Mol Biol; 2007 Jun; 369(4):1001-14. PubMed ID: 17481659 [TBL] [Abstract][Full Text] [Related]
15. Morph-X-Select: Morphology-based tissue aptamer selection for ovarian cancer biomarker discovery. Wang H; Li X; Volk DE; Lokesh GL; Elizondo-Riojas MA; Li L; Nick AM; Sood AK; Rosenblatt KP; Gorenstein DG Biotechniques; 2016; 61(5):249-259. PubMed ID: 27839510 [TBL] [Abstract][Full Text] [Related]
16. Solid-Phase Synthesis of Oligodeoxynucleotide Analogs Containing Phosphorodithioate Linkages. Yang X Curr Protoc Nucleic Acid Chem; 2016 Sep; 66():4.71.1-4.71.14. PubMed ID: 27584703 [TBL] [Abstract][Full Text] [Related]
17. Selection of a novel DNA thioaptamer against HER2 structure. Hu Y; Duan J; Cao B; Zhang L; Lu X; Wang F; Yao F; Zhu Z; Yuan W; Wang C; Yang XD Clin Transl Oncol; 2015 Aug; 17(8):647-56. PubMed ID: 26022131 [TBL] [Abstract][Full Text] [Related]
18. CpG DNA rescue from anti-IgM-induced WEHI-231 B lymphoma apoptosis via modulation of I kappa B alpha and I kappa B beta and sustained activation of nuclear factor-kappa B/c-Rel. Yi AK; Krieg AM J Immunol; 1998 Feb; 160(3):1240-5. PubMed ID: 9570540 [TBL] [Abstract][Full Text] [Related]
19. Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting. Missailidis S; Thomaidou D; Borbas KE; Price MR J Immunol Methods; 2005 Jan; 296(1-2):45-62. PubMed ID: 15680150 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus activity by phosphorodithioate oligodeoxycytidine. Marshall WS; Beaton G; Stein CA; Matsukura M; Caruthers MH Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6265-9. PubMed ID: 1378623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]